96 related articles for article (PubMed ID: 2245174)
1. Alterations in serum lipolytic activity of cancer patients with response to therapy.
Beck SA; Groundwater P; Barton C; Tisdale MJ
Br J Cancer; 1990 Nov; 62(5):822-5. PubMed ID: 2245174
[TBL] [Abstract][Full Text] [Related]
2. Alteration of serum and urinary lipolytic activity with weight loss in cachectic cancer patients.
Groundwater P; Beck SA; Barton C; Adamson C; Ferrier IN; Tisdale MJ
Br J Cancer; 1990 Nov; 62(5):816-21. PubMed ID: 2245173
[TBL] [Abstract][Full Text] [Related]
3. Effect of megestrol acetate on weight loss induced by tumour necrosis factor alpha and a cachexia-inducing tumour (MAC16) in NMRI mice.
Beck SA; Tisdale MJ
Br J Cancer; 1990 Sep; 62(3):420-4. PubMed ID: 2206950
[TBL] [Abstract][Full Text] [Related]
4. Effects of progestogens on lipemia and lipolysis in rat: effects of progesterone, megestrol acetate, norethindrone acetate, and nomegestrol acetate.
Hazard MC; Clavet M; Chapignac A; Paris J
Fundam Clin Pharmacol; 1987; 1(4):233-42. PubMed ID: 3436613
[TBL] [Abstract][Full Text] [Related]
5. An overview of megestrol acetate for the treatment of advanced breast cancer.
Sedlacek SM
Semin Oncol; 1988 Apr; 15(2 Suppl 1):3-13. PubMed ID: 3285483
[TBL] [Abstract][Full Text] [Related]
6. Treatment of anorexia and weight loss with megestrol acetate in patients with cancer or acquired immunodeficiency syndrome.
Tchekmedyian NS; Hickman M; Heber D
Semin Oncol; 1991 Feb; 18(1 Suppl 2):35-42. PubMed ID: 1992535
[TBL] [Abstract][Full Text] [Related]
7. Randomized double-blind placebo-controlled trial of cisplatin and etoposide plus megestrol acetate/placebo in extensive-stage small-cell lung cancer: a North Central Cancer Treatment Group study.
Rowland KM; Loprinzi CL; Shaw EG; Maksymiuk AW; Kuross SA; Jung SH; Kugler JW; Tschetter LK; Ghosh C; Schaefer PL; Owen D; Washburn JH; Webb TA; Mailliard JA; Jett JR
J Clin Oncol; 1996 Jan; 14(1):135-41. PubMed ID: 8558188
[TBL] [Abstract][Full Text] [Related]
8. High-dose megestrol acetate therapy of ovarian carcinoma: a phase II study by the Northern California Oncology Group.
Sikic BI; Scudder SA; Ballon SC; Soriero OM; Christman JE; Suey L; Ehsan MN; Brandt AE; Evans TL
Semin Oncol; 1986 Dec; 13(4 Suppl 4):26-32. PubMed ID: 3099393
[TBL] [Abstract][Full Text] [Related]
9. Lipolytic factors associated with murine and human cancer cachexia.
Beck SA; Mulligan HD; Tisdale MJ
J Natl Cancer Inst; 1990 Dec; 82(24):1922-6. PubMed ID: 2250313
[TBL] [Abstract][Full Text] [Related]
10. Lipid mobilising factors specifically associated with cancer cachexia.
Beck SA; Tisdale MJ
Br J Cancer; 1991 Jun; 63(6):846-50. PubMed ID: 2069843
[TBL] [Abstract][Full Text] [Related]
11. High-dose megestrol acetate. A possible treatment for cachexia.
Tchekmedyian NS; Tait N; Moody M; Aisner J
JAMA; 1987 Mar; 257(9):1195-8. PubMed ID: 3806918
[TBL] [Abstract][Full Text] [Related]
12. Megestrol acetate in cancer cachexia.
Schmoll E; Wilke H; Thole R; Preusser P; Wildfang I; Schmoll HJ
Semin Oncol; 1991 Feb; 18(1 Suppl 2):32-4. PubMed ID: 1992534
[TBL] [Abstract][Full Text] [Related]
13. Risks and benefits of various therapies for cancer anorexia.
Schmoll E
Oncology; 1992; 49 Suppl 2():43-5. PubMed ID: 1461627
[TBL] [Abstract][Full Text] [Related]
14. Megestrol acetate for anorexia and cachexia.
Loprinzi CL; Johnson PA; Jensen M
Oncology; 1992; 49 Suppl 2():46-9. PubMed ID: 1461628
[TBL] [Abstract][Full Text] [Related]
15. Comparison of antiestrogen and progestogen therapy for initial treatment and consequences of their combination for second-line treatment of recurrent breast cancer.
Paterson AH; Hanson J; Pritchard KI; Sansregret E; Dahrouge S; McDermot RS; Fine S; White DF; Trudeau M; Stewart DJ
Semin Oncol; 1990 Dec; 17(6 Suppl 9):52-62. PubMed ID: 2259927
[TBL] [Abstract][Full Text] [Related]
16. Treatment of cancer weight loss in patients with advanced lung cancer.
Heckmayr M; Gatzemeier U
Oncology; 1992; 49 Suppl 2():32-4. PubMed ID: 1461625
[TBL] [Abstract][Full Text] [Related]
17. Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study.
Jatoi A; Windschitl HE; Loprinzi CL; Sloan JA; Dakhil SR; Mailliard JA; Pundaleeka S; Kardinal CG; Fitch TR; Krook JE; Novotny PJ; Christensen B
J Clin Oncol; 2002 Jan; 20(2):567-73. PubMed ID: 11786587
[TBL] [Abstract][Full Text] [Related]
18. Influence of adipocyte size and adipose depot on the in vitro lipolytic activity and insulin sensitivity of adipose tissue in dairy cows at the end of the dry period.
De Koster J; Van den Broeck W; Hulpio L; Claeys E; Van Eetvelde M; Hermans K; Hostens M; Fievez V; Opsomer G
J Dairy Sci; 2016 Mar; 99(3):2319-2328. PubMed ID: 26723122
[TBL] [Abstract][Full Text] [Related]
19. Prospective randomised trial of two dose levels of megestrol acetate in the management of anorexia-cachexia syndrome in patients with metastatic cancer.
Gebbia V; Testa A; Gebbia N
Br J Cancer; 1996 Jun; 73(12):1576-80. PubMed ID: 8664133
[TBL] [Abstract][Full Text] [Related]
20. Treatment of anorexia with megestrol acetate.
Tchekmedyian NS
Nutr Clin Pract; 1993 Jun; 8(3):115-8. PubMed ID: 8289758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
